Home
Career Stage
Medical Students Residents Attendings CPT Codes Resources Blog Support

J9326 Telisotuzumab vedotin-tllv

J Codes (Drugs)

Also known as: telisotuzumab vedotin, Subtam

Injection of telisotuzumab vedotin-tllv, an antibody-drug conjugate targeting c-Met receptor. Used for solid tumors with c-Met expression.

In Plain Language

lung cancer injection; targeted therapy drug

Clinical Context

Used for metastatic non-small cell lung cancer with c-Met expression. Antibody-drug conjugate targeting hepatocyte growth factor receptor.

RVU Information

CPT J9326 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.

Billing & Documentation

J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.

Specialties

OncologyPulmonologySurgery

Frequently Asked Questions

What is CPT code J9326?

CPT J9326 (Telisotuzumab vedotin-tllv) is a J Codes (Drugs) code. Injection of telisotuzumab vedotin-tllv, an antibody-drug conjugate targeting c-Met receptor. Used for solid tumors with c-Met expression.

How is J9326 administered?

CPT J9326 is administered by a healthcare provider, typically via injection or infusion. Used for metastatic non-small cell lung cancer with c-Met expression. Antibody-drug conjugate targeting hepatocyte growth factor receptor. It is used by Oncology, Pulmonology, Surgery.

When is CPT J9326 used?

Used for metastatic non-small cell lung cancer with c-Met expression. Antibody-drug conjugate targeting hepatocyte growth factor receptor.

Track This Code in RVU Edge

Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.

CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.